Evaluation of Leptin Serum Concentrations During Surgery and First-Line Chemotherapy in Primary Epithelial Ovarian Cancer Patients

Wspolczesna Onkologia - Poland
doi 10.5114/wo.2014.46323
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

TIMP-1 and VEGF-165 Serum Concentration During First-Line Therapy of Ovarian Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

Could HE4 Level Measurements During First-Line Chemotherapy Predict Response to Treatment Among Ovarian Cancer Patients?

PLoS ONE
Multidisciplinary
2018English

Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer

Cochrane Database of Systematic Reviews
2016English

Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer

2005English

Survival After Secondary Cytoreductive Surgery and Chemotherapy Compared With Chemotherapy Alone for First Recurrence in Patients With Platinum-Sensitive Epithelial Ovarian Cancer and No Residuals After Primary Treatment. A Registry-Based Study

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2018English

Prognostic Evaluation of Preoperative Serum C-Reactive Protein Concentration in Patients With Epithelial Ovarian Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Real World Treatment Patterns of Patients With Ovarian Cancer Receiving First Line Chemotherapy in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Prognostic Role of Preoperative Serum Albumin in Patients With Advanced Ovarian Cancer Undergoing Primary Debulking Surgery

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy